Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
search-icon-img
  • ftr-facebook
  • ftr-instagram
  • ftr-instagram
search-icon-img
Advertisement

Study gives new insight into cause of inner-ear bone loss

Osaka, August 3 A person’s hearing and balance may be impacted by a number of issues and difficulties brought on by persistent middle ear inflammation. A common issue is the development of cholesteatomas, which are aberrant ear collections of cells...
  • fb
  • twitter
  • whatsapp
  • whatsapp
Advertisement

Osaka, August 3

A person’s hearing and balance may be impacted by a number of issues and difficulties brought on by persistent middle ear inflammation.

A common issue is the development of cholesteatomas, which are aberrant ear collections of cells that, if addressed, can lead to bone erosion. Consequently, this may result in symptoms including vertigo, facial paralysis, hearing loss, and even brain infection.

Advertisement

In a study published recently inNature Communications, researchers from Osaka University have revealed the cause of cholesteatomas, which may help in developing new therapies for patients who are suffering from this disease.

Cholesteatomas are made up of cysts or bumps in the ear that consist of skin, collagen fibers, skin cells, fibroblasts, keratin, and dead tissue. There are many theories on how these cholesteatomas can cause bone erosion, including the activation of cells responsible for the breakdown of the minerals and matrix of the bone, the presence of inflammatory markers and enzymes, and the accumulation and pressure from dead cells and tissues in the ear; however, the exact mechanism for the creation of cholesteatomas remains unknown.

Advertisement

A cholesteatoma can still return or happen again even after its surgical removal, so it is important to know what is actually causing, says lead author Kotaro Shimizu.

To investigate this, researchers looked at human cholesteatoma tissues that were surgically removed from patients. A process called single-cell RNA sequencing analysis was employed to identify cells responsible for triggering bone erosion; these were called osteoclastogenic fibroblasts. This study demonstrated how these fibroblasts expressed an abundant amount of activin A, a molecule that regulates different physiologic functions of the body. The presence of activin A is said to cause bone erosion through a process in which specialized cells initiate bone resorption through a process wherein the minerals and matrix of the bones are broken down and absorbed by the body.

Advertisement
Advertisement
Advertisement
Advertisement
tlbr_img1 Home tlbr_img2 Opinion tlbr_img3 Classifieds tlbr_img4 Videos tlbr_img5 E-Paper